Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX) in a research note issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Price Performance

Shares of NASDAQ:ATHX opened at $0.00 on Friday. The stock has a market cap of $222,188.40, a P/E ratio of 0.00 and a beta of -0.90. The firm has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.02. Athersys has a 1-year low of $0.01 and a 1-year high of $1.99.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.